Article
[Hypotensive effect of encapsulated genetically engineered fibroblasts expressing mutant atrial natriuretic peptide in hypertensive rats].
Zhonghua yi xue za zhi - 25 Aug 2002
Li Tao, Liang Hongyan, Lu Guo, Shi Ruiwen, Lu Shengdong
Abstract excerpt
OBJECTIVE: To study the inhibitive effect of subcutaneous implantation of capsule filled with fibroblasts engineered to secrete the mutant human atrial natriuretic peptide (mhANP) on blood pressure in young spontaneously hypertensive rats (SHR) and to explore the feasibility of gene therapy for the treatment of hypertension. METHODS: A recombinant retroviral vector pLHY24 bearing mhANP cDNA was constructed....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
